SAFE

No contraindications
Medical device class IIa (EU MDD)

SPECIFIC

Extracorporeal endotoxin elimination in hemoperfusion

EFFECTIVE

Results in 2 hours
1 treatment = 1 adsorber 

Sepsis is one of the most common causes of death in modern intensive care. With nearly 49 million cases and 11 million deaths per year – or 1 in 5 – it is now thought that sepsis kills more people than cancer. 1

Take endotoxin out of the picture!

Safe, specific and effective

The Alteco LPS Adsorber is a medical device used for treatment of endotoxemia and/or sepsis or septic shock caused by suspected or verified gram-negative bacteria. By removing endotoxin from the bloodstream during extracorporeal treatment, Alteco LPS Adsorber can turn the course of sepsis and stabilize the patient’s hemodynamic parameters in 2 hours. 2

Turn the course of sepsis

High levels of endotoxin activity are associated with organ failure and death. 3 Therefore, starting treatment early is important. Use the Alteco LPS Adsorber to counteract the critical and life-threatening part of the sepsis process. Remove endotoxin from the bloodstream to regain control over the systemic failure and stabilize the patient in the acute situation.

Treatment results

Post treatment, patients usually demonstrate a reduction in endotoxin, procalcitonin and lactate levels, a reduction or elimination of vasopressor support , stability and improvement in hemodynamic parameters as well as SOFA score.

Removing the threat

Our mission is to safely stabilize patients by early removal of endotoxin from the bloodstream during extracorporeal treatment, turning the course of sepsis before septic shock occurs.

Get the latest updates

    News and events

    Alteco Medical continues to expand into new markets across the world and added several new distributors in July 2021.
    Alteco Medical has signed a distributor agreement with B.Braun Medical SA, Spain.
    Alteco Medical has signed a new distributor agreement with Adsorpio UG, covering the German market.
    Bacterial translocation from GI-tract might complicate severe COVID-19. Bacterial products might be another possible contributor to the cytokine storm.
    Jakub Smiechowicz, Barbara Adamik, Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Poland
    Webinar: Selective adsorption therapies - adsorption of gram-negative endotoxins (in Portugese)